Victoria P. Werth, M.D.

faculty photo
Professor of Dermatology at the Hospital of the University of Pennsylvania and the Veteran's Administration Medical Center
Department: Dermatology

Contact information
Division of Dermatology
Veterans Administration Hospital
University and Woodland Avenues
Philadelphia, PA 19104
Office: 215-823-4208
Fax: 215-823-5171
Education:
B.A. (Chemistry)
Catholic University, 1976.
M.S. (Physical Chemistry)
Catholic University, 1976.
M.D. (Medicine)
Johns Hopkins University, 1980.
Post-Graduate Training
Intern in Medicine, Northwestern Memorial Hospital, Chicago, 1980-1981.
Resident in Internal Medicine, Northwestern Memorial Hospital, Chicago, 1981-1983.
Resident in Dermatology, New York University, 1983-1986.
Chief Resident in Dermatology, New York University, 1985-1986.
Research Fellow in Dermatology, New York University, 1986-1988.
Dermatology Foundation Fellow, New York University, 1987-1989.
Certifications
American Board of Internal Medicine, 1983.
American Board of Dermatology, 1986.
American Boards of Immunodermatology and Immunopathology, 1989.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Description of Research Expertise

Photobiology
Tumor necrosis factor
Cutaneous lupus
Glycosaminoglycans
Clinical and translational research in cutaneous autoimmune diseases

Description of Clinical Expertise

Autoimmune skin disease
Cutaneous Lupus Erythematosus
Dermatomyositis
Pemphigus vulgaris

Selected Publications

Murrell DF, Boucher D, Daneshpazhooh M, Mahmoudi H, Kianfar N, … Werth VP: International development of Investigator Global Assessment scores for pemphigus. J Eur Acad Dermatol Venereol Apr 2026 Notes: Epub ahead of print.

Aly S, Parastandehchehr G, Bernatsky S, Vinet É, Arnaud L, Costedoat-Chalumeau N, Fortin PR, Reynolds JA, Thorne JC, Touma Z, Wallace D, Werth VP, Singer W, Mendel A: A Global Survey of Quinacrine Use in Systemic and Cutaneous Lupus Erythematosus J Rheumatol 53(3): 292-296, Mar 2026.

Vleugels RA, Paik JJ, Bauer Ventura I, Mangold AR, Gandiga PC, Haemel A, Chinoy H, Hussain YM, Sivakumar K, Zoltan G, Lee EB, Bozan F, Hsu CY, Femia A, Dimachkie MM, Min MS, Mozaffar T, Charles-Schoeman C, Fernandez DR, Onajin O, Marques R, Marder G, Ernste F, Schiopu E, Sluzevich J, Pearson D, Lindsey S, Luggen M, Bubb MR, Boh E, Maganti R, Heinlen L, Shaw KS, Cascino MD, Mudd PN Jr, Vencovsky J, Fernandez AP, Fiorentino D, Christopher-Stine L, Werth VP, Aggarwal R; VALOR Investigators: A Phase 3 Trial of Brepocitinib in Dermatomyositis. N Engl J Med Mar 2026 Notes: Epub ahead of print.

Wei E, Lopes Almeida Gomes L, Jun S, Saksena S, Werth VP: Therapeutic Approaches for Cutaneous Lupus Erythematosus: a Changing Landscape of Clinical Trials. J Inflamm Res Feb 2026.

Khosravi-Hafshejani T, Ali H, Lopes Almeida Gomes L, Werth VP: Environmental Exposures of Concern for Rheumatologists: Ultraviolet Radiation. Rheum Dis Clin North Am 52(1): 103-119, Feb 2026.

Baniel A, Momohara-Ogawa M, Bahir M, Pandya R, Kleitsch J, Chin F, Vijayarangan N, Cohen S, Johnson C, Fazelinia H, Spruce L, Werth VP: Dysregulated Pathways and Potential Biomarkers in Dermatomyositis Plasma-Derived Extracellular Vesicles - A Pilot Study. J Invest Dermatol 146(2): 541-544, Feb 2026.

Korte EWH, Hiel MAJ, Bolling MC, Dunn P, Murrell DF, Werth VP, Yale M, Spuls PI, Meijer JM, Horváth B: Navigating challenges in clinical trials for bulbous pemphigoid and pemphigus: learnings from the clinical trial graveyard and an international expert survey. Br J Dermatol 194(1): 165-167, Jan 2026.

Chambers S, Hill A, Yang X, On A, Lopes Ameida Gomes L, Khosravi-Hafshejani T, Ali H, Perez O, Bell S, Donovan C, Adjei T, Werth VP: Barriers to clinical trial access among Black lupus patients. Lupus Dec 2025.

Peters ZT, Mendyka LK, Blake J, Goswami HB, Cortez AN, Crossland GE, Shan S, Nowak EC, Mrinal S, Johann EG, Burns CM, Barton DT, Blazar BR, Curiel TJ, Mabaera R, Werth VP, Kalus A, Elkon K, Noelle RJ, Skopelja-Gardner S: . Keratinocyte VISTA attenuates UV light-induced skin injury by suppressing cutaneous type I interferon (IFN-I) response. bioRxiv [Preprint] Dec 2025.

Weiner JD, Hill A, Shen C, On A, Werth VP: Identifying immunostimulatory herbal supplements that may flare autoimmune skin diseases: a systematic scoping review. Lupus Sci Med 12(2), Dec 2025.

back to top
Last updated: 04/30/2026
The Trustees of the University of Pennsylvania